Qual é o preço para D. Western Therapeutics Institute, Inc. (4576)

O preço para D. Western Therapeutics Institute, Inc. (4576) é $0.57414457

Qual é a capitalização de mercado para D. Western Therapeutics Institute, Inc. (4576)

A capitalização de mercado para D. Western Therapeutics Institute, Inc. (4576) é $33.00M

D. Western Therapeutics Institute, Inc. (4576) Preço e Capitalização de Mercado

D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting bullous keratopathy, and DW-1002, an ophthalmic surgical aid used for staining membranes like ILM, ALC, ERM, and PVR during cataract operations. In its development pipeline, the company is advancing DW-5LBT, a lidocaine patch designed to alleviate neuropathic pain post-shingles. Additionally, K-321 is progressing through Phase III clinical trials for Fuch endothelial corneal dystrophy, and H-1337, a multi-kinase inhibitor, has commenced Phase IIb trials for glaucoma and ocular hypertension treatment. The firm was established in 1999 and operates from its headquarters in Nagoya, Japan.

Preço para 4576	Ativo B	Capitalização de mercado de B	Resultados
$92,227.91 $33.00M	NVDA	$5.301T	+16,063,433.89%
$80,623.02 $33.00M	AAPL	$4.634T	+14,042,184.63%
$72,082.24 $33.00M	GOOG	$4.143T	+12,554,619.81%
$62,450.21 $33.00M	MSFT	$3.589T	+10,876,988.64%
$49,707.03 $33.00M	AMZN	$2.857T	+8,657,480.48%

Preço para 4576

Ativo B

Capitalização de mercado de B

Resultados

$92,227.91 $33.00M